News & Press Release
2011
- All Categories
- For the Press
- Announcements
- HR and Organization
- Product Information
-
- 2011-12-09 HR and Organization Announcement of Personnel Assignments
- 2011-11-17 Product Information NHI Drug Price listing of Fostoin® 750mg for Injection (NPC-06 Fosphenytoin)
- 2011-11-16 Product Information NPC-10 Streptozocin designated as an orphan drug.
- 2011-11-12 Product Information Submitted application for approval of Manufacturing and Marketing Authorization of NPC-08 Gliadel® Wafer (Carmustine).
- 2011-11-11 Announcements President Shiomura gave a press conference at the Foreign Correspondent’s Club of Japan.
- 2011-11-02 Announcements President Shiomura spoke at the Japan Society of Pediatric Clinical Pharmacology and Therapeutics Symposium.
- 2011-11-01 HR and Organization Announcement of Personnel Assignments
- 2011-10-02 Announcements President Shiomura spoke at the Japan Health Sciences Foundation.
- 2011-09-01 Announcements License Agreement with Clinigen for FoscavirR (Antivirus medicine) sales right
- 2011-08-02 Announcements As a Director of SAMURAI Biotech Association, President Shiomura was appointed as a constituent member of the Study Group for Stimulation of Clinical Research and Trials
- 2011-08-01 Product Information NPC-11 Caffeine Citrate was designated as the orphan drug.
- 2011-07-02 HR and Organization Training session for all employees held in Atami, two days, one night
- 2011-06-29 HR and Organization Announcement of Organizational Changes and Personnel Assignments
- 2011-06-10 Announcements Sendai office opening reception
- 2011-06-08 Announcements Announcement of Start of Phase III Trial of Drug for Apnea of Prematurity
- 1
- 2